SCHEMBL1876971

SCHEMBL1876971

O=C1CC[N]CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10305 0.85
SCHEMBL1877540 0.81
SCHEMBL597073 0.78
2-Pyrrolidone SCHEMBL2389 0.73
2-Pyrrolidone SCHEMBL2167448 0.73 OR51E2 (1.00)
2-Pyrrolidone SCHEMBL9304498 0.73 OR51E2 (1.00)
2-Pyrrolidone SCHEMBL4299593 0.73
2-Pyrrolidone SCHEMBL27827832 0.73
SCHEMBL596754 0.72
2-Pyrrolidone SCHEMBL11328078 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947690-B2 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example ASTELLAS PHARMA INC. (JP) 2011-05-24 US disclosed
US-20080070896-A1 Pyrimidine Derivative Condensed with a Non-Aromatic Ring ASTELLAS PHARMA INC. (JP) 2008-03-20 US disclosed
EP-1803710-A1 PYRIMIDINE DERIVATIVE CONDENSED WITH NON-AROMATIC RING Astellas Pharma Inc. (JP) 2007-07-04 EP disclosed